Institutional investors hold a majority ownership of PCRX through the 117.94% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended March 2016, these large investors purchased a net $898.2 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FOX RUN MANAGEMENT LLC Bought 13.3 Thousand shares of Pacira Pharmaceuticals In...